These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. [Hormonal contraception]. Imparato E Rass Int Clin Ter; 1970 Jan; 50(2):86-96. PubMed ID: 5436775 [No Abstract] [Full Text] [Related]
66. [Complications of hormonal contraception with estrogen and gestagens in the climacteric and in the postmenopausal period. 39th Congress of the "Zurich Discussion Group", October 2007]. Birkhäuser M; Braendle W; Kuhl H; Neulen J; Thaler CJ Gynakol Geburtshilfliche Rundsch; 2009; 49(1):45-51. PubMed ID: 19204402 [No Abstract] [Full Text] [Related]
67. Safety of oral contraceptives related to steroid content: a critical review. Sturtevant FM Int J Fertil; 1989; 34(5):323-32. PubMed ID: 2571592 [TBL] [Abstract][Full Text] [Related]
68. [Options of hormonal contraceptives and substitution in female diabetic patients]. Sadlonová J Vnitr Lek; 2009 Apr; 55(4):375-83. PubMed ID: 19449754 [TBL] [Abstract][Full Text] [Related]
69. Red cell deformability in oral contraceptive pill users with sickle cell anaemia. Yoong WC; Tuck SM; Yardumian A Br J Haematol; 1999 Mar; 104(4):868-70. PubMed ID: 10192452 [TBL] [Abstract][Full Text] [Related]
70. [Female hormones and oral health]. Meijer van Putten JB Ned Tijdschr Tandheelkd; 1998 Nov; 105(11):416-8. PubMed ID: 11928463 [TBL] [Abstract][Full Text] [Related]
71. The transdermal patch and the vaginal ring: two novel methods of combined hormonal contraception. Swica Y Obstet Gynecol Clin North Am; 2007 Mar; 34(1):31-42, viii. PubMed ID: 17472863 [TBL] [Abstract][Full Text] [Related]
73. Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa). Shapiro S; Rosenberg L; Hoffman M; Kelly JP; Cooper DD; Carrara H; Denny LE; du Toit G; Allan BR; Stander IA; Williamson AL Cancer Causes Control; 2003 Jun; 14(5):485-95. PubMed ID: 12946044 [TBL] [Abstract][Full Text] [Related]
74. Contraceptives' role in HIV transmission is examined. AIDS Alert; 1996 Mar; 11(3):30-1. PubMed ID: 11363241 [TBL] [Abstract][Full Text] [Related]
75. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study. Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759 [TBL] [Abstract][Full Text] [Related]
76. [The risk-benefit balance of estrogen-progestogen hormonal contraception]. Plu-Bureau G; Raccah-Tebeka B Med Sci (Paris); 2022 Jan; 38(1):59-69. PubMed ID: 35060888 [TBL] [Abstract][Full Text] [Related]
77. [Calculation of estrogenic and gestagenic activity of oral hormonal contraceptive agents including a tabular review]. Kless-Och M Schweiz Rundsch Med Prax; 1972 Nov; 61(46):1418-24. PubMed ID: 5084999 [No Abstract] [Full Text] [Related]
78. [Benefits and risk of the modern combined hormonal contraception]. Fait T; Nouzová K; Sýkorová P; Fanta M; Vrablík M; Skrenková J Cas Lek Cesk; 2005; 144(4):238-44. PubMed ID: 15945482 [TBL] [Abstract][Full Text] [Related]
79. Helping women choose appropriate hormonal contraception: update on risks, benefits, and indications. Spencer AL; Bonnema R; McNamara MC Am J Med; 2009 Jun; 122(6):497-506. PubMed ID: 19486709 [TBL] [Abstract][Full Text] [Related]
80. Oestroprogestagens and severe acute pyelonephritis: a casual or causal association? Piccoli GB; Colla L; Mezza E; Burdese M; Cammarota T; Piccoli G Nephrol Dial Transplant; 2006 Aug; 21(8):2337. PubMed ID: 16868038 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]